Evidence map›Paper›PMID 40593422›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Probing Antibody Binding Sites on G Protein-Coupled Receptors Using Genetically Encoded Photo-Activatable Cross-Linkers.

Victoria R Saca, Jordan M Mattheisen, Thomas Huber, Thomas P Sakmar

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Victoria R SacaLaboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, USA.
Jordan M MattheisenLaboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, USA.
Thomas HuberLaboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, USA.
Thomas P SakmarLaboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, USA. sakmar@rockefeller.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe a methodology to map epitopes of monoclonal antibodies (mAbs) that bind to G protein-coupled receptors (GPCRs). The method involves using genetic code expansion technology to introduce a non-canonical amino acid (ncAA) residue into an expressed GPCR that can serve as a photo-activatable cross-linkers in mammalian cells in culture. Interaction sites between the engineered receptor variants and the cognate mAb are mapped by determining which of the p-azido-L-phenylalanine (azF) or p-benzoyl-L-phenylalanine (BzF) residues cross-link to the mAb upon ultraviolet (UV) irradiation. These sites are compared with the sites of amino acid replacements that cause loss of mAb binding to create a surface binding map of the mAb epitope. The precision of the GPCR-mAb binding-site map is dependent on the number of receptor mutants studied and the availability of a high-resolution three-dimensional structural models. One advantage of the method is that anti-receptor mAbs with discontinuous epitopes may also be elucidated. In addition, the method is also applicable to map the cell-surface epitopes of mAbs targeting proteins other than GPCRs.

Indexed as

Antibodies, MonoclonalBinding Sites, AntibodyCross-Linking ReagentsEpitope MappingReceptors, G-Protein-CoupledAnimalsAzidesBinding SitesEpitopesHumansPhenylalanine4-azidophenylalanineAntibodies, MonoclonalAzidesCross-Linking ReagentsEpitopesPhenylalanineReceptors, G-Protein-CoupledAmber codonAntibodyEpitope mapG protein-coupled receptorPhoto-activatable cross-linkers

Identifiers

PMID40593422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.